Title:
A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) With High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin and Etoposide (TI-CE) as First Salvage Treatment in Relapsed or Refractory Germ Cell Tumors
Phase:
III
Contact:
Mirjam Campbell / Kontaktperson
Email-Address:
Mirjam.Campbell@med.uni-heidelberg.de
Clinical Investigator:
Dr. Stefanie Zschäbitz
Registration:
Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe
NCT02375204
EudraCT-Number:
(siehe EU klinisches Studienregister)
2014-003930-17